ID

13081

Beschreibung

Flavopiridol in Treating Patients With Recurrent Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00003256

Link

https://clinicaltrials.gov/show/NCT00003256

Stichworte

  1. 15.01.16 15.01.16 -
Rechteinhaber

CC BY-NC 3.0

Hochgeladen am

15. Januar 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Prostate Cancer NCT00003256

Eligibility Prostate Cancer NCT00003256

Criteria
Beschreibung

Criteria

performance status: ecog 0-2
Beschreibung

ecog

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy: at least 3 months
Beschreibung

life expectancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
wbc at least 3,000/mm3
Beschreibung

leukocytes

Datentyp

boolean

Alias
UMLS CUI [1]
C0023508
absolute neutrophil count at least 1,200/mm3
Beschreibung

absolute neutrophil count

Datentyp

boolean

Alias
UMLS CUI [1]
C0948762
platelet count at least 100,000/mm3
Beschreibung

platelet count

Datentyp

boolean

Alias
UMLS CUI [1]
C0005821
hemoglobin at least 8 g/dl
Beschreibung

hemoglobin

Datentyp

boolean

Alias
UMLS CUI [1]
C0019046
bilirubin no greater than 1.5 mg/dl
Beschreibung

bilirubin

Datentyp

boolean

Alias
UMLS CUI [1]
C1278039
sgot no greater than 2.5 times normal
Beschreibung

sgot

Datentyp

boolean

Alias
UMLS CUI [1]
C0201899
creatinine no greater than 1.5 mg/dl
Beschreibung

creatinine

Datentyp

boolean

Alias
UMLS CUI [1]
C0201976
prostate-specific antigen at least 10 ng/ml (if bone only disease)
Beschreibung

prostate-specific antigen

Datentyp

boolean

Alias
UMLS CUI [1]
C0138741
no prior or concurrent maligancies within 5 years, except nonmelanoma skin cancer
Beschreibung

prior malignancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0006826
no serious medical illness
Beschreibung

serious medical illness

Datentyp

boolean

Alias
UMLS CUI [1]
C0009488
no cord compression symptoms
Beschreibung

cord compression symptoms

Datentyp

boolean

Alias
UMLS CUI [1]
C0037926
no prior chemotherapy
Beschreibung

chemotherapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0392920
no prior suramin therapy
Beschreibung

suramin

Datentyp

boolean

Alias
UMLS CUI [1]
C0813205
prior or concurrent use of luteinizing hormone-releasing hormone allowed (no other concurrent hormonal therapy)
Beschreibung

LHRH therapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0023610
no prior anti-androgen therapy within 4 weeks of study
Beschreibung

anti-androgen

Datentyp

boolean

Alias
UMLS CUI [1]
C0279492
at least 4 weeks since prior radiotherapy
Beschreibung

radiotherapy

Datentyp

boolean

Alias
UMLS CUI [1]
C1522449
no prior strontium therapy
Beschreibung

strontium

Datentyp

boolean

Alias
UMLS CUI [1]
C0038467

Ähnliche Modelle

Eligibility Prostate Cancer NCT00003256

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
ecog
Item
performance status: ecog 0-2
boolean
C1520224 (UMLS CUI [1])
life expectancy
Item
life expectancy: at least 3 months
boolean
C0023671 (UMLS CUI [1])
leukocytes
Item
wbc at least 3,000/mm3
boolean
C0023508 (UMLS CUI [1])
absolute neutrophil count
Item
absolute neutrophil count at least 1,200/mm3
boolean
C0948762 (UMLS CUI [1])
platelet count
Item
platelet count at least 100,000/mm3
boolean
C0005821 (UMLS CUI [1])
hemoglobin
Item
hemoglobin at least 8 g/dl
boolean
C0019046 (UMLS CUI [1])
bilirubin
Item
bilirubin no greater than 1.5 mg/dl
boolean
C1278039 (UMLS CUI [1])
sgot
Item
sgot no greater than 2.5 times normal
boolean
C0201899 (UMLS CUI [1])
creatinine
Item
creatinine no greater than 1.5 mg/dl
boolean
C0201976 (UMLS CUI [1])
prostate-specific antigen
Item
prostate-specific antigen at least 10 ng/ml (if bone only disease)
boolean
C0138741 (UMLS CUI [1])
prior malignancy
Item
no prior or concurrent maligancies within 5 years, except nonmelanoma skin cancer
boolean
C0006826 (UMLS CUI [1])
serious medical illness
Item
no serious medical illness
boolean
C0009488 (UMLS CUI [1])
cord compression symptoms
Item
no cord compression symptoms
boolean
C0037926 (UMLS CUI [1])
chemotherapy
Item
no prior chemotherapy
boolean
C0392920 (UMLS CUI [1])
suramin
Item
no prior suramin therapy
boolean
C0813205 (UMLS CUI [1])
LHRH therapy
Item
prior or concurrent use of luteinizing hormone-releasing hormone allowed (no other concurrent hormonal therapy)
boolean
C0023610 (UMLS CUI [1])
anti-androgen
Item
no prior anti-androgen therapy within 4 weeks of study
boolean
C0279492 (UMLS CUI [1])
radiotherapy
Item
at least 4 weeks since prior radiotherapy
boolean
C1522449 (UMLS CUI [1])
strontium
Item
no prior strontium therapy
boolean
C0038467 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video